RxDoctor Payments Data

Hanifa Waarith

Family Medicine · Gary, INNPI 1205426723

Payments from drug & device makers

$1,056in general payments, 2019–2025

Across 35 payments — averaging $30.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Simplicity, LLC$135
  • Boston Scientific$123
  • AstraZeneca$115
  • AbbVie$101
  • Dexcom, Inc.$88
  • Vertos Medical, Inc.$86
  • plus $408 from 15 others

What the payments were for

  • Food & beverage$1,056100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,056 in reported general payments places this provider in the 60th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$65,212
Medicare patients
297
Services billed
699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen887$16,064
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen262$7,867
Naloxone Hcl62$3,062
Pregabalin76$1,885
Lidocaine24$1,485
Gabapentin143$1,225
Tramadol Hcl116$734
Morphine Sulfate ErMorphine Sulfate29$645
Morphine Sulfate25$568
Oxycodone Hcl33$563
Cyclobenzaprine Hcl59$387
Tizanidine Hcl53$363
Acetaminophen-CodeineAcetaminophen With Codeine21$362
Methocarbamol11$109
Meloxicam11$21

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USAMorphine Sulfate$17$56825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Gary

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →